SUD APCM EHR Documentation Workflow Guide
Master APCM EHR documentation for Substance Use Disorders. Learn 42 CFR Part 2 compliance and MAT monitoring workflows to maximize BHI add-on revenue.
Effective APCM for Substance Use Disorders requires more than just clinical notes; it demands a structured documentation workflow that integrates 42 CFR Part 2 consent with longitudinal MAT monitoring. This guide outlines how to leverage AI-powered call handling to automate check-ins and ensure every encounter meets the 2026 BHI add-on requirements for G0568-G0570.
SUD practices often lose APCM revenue due to fragmented documentation, failure to capture the required 20 minutes of non-face-to-face care, and the administrative burden of manual relapse prevention follow-ups while maintaining strict 42 CFR Part 2 confidentiality standards.
Step-by-Step Workflow
Initial APCM Enrollment & 42 CFR Part 2 Consent Capture
Securely document patient consent for APCM services and the specific sharing of SUD records, ensuring the electronic signature is timestamped and linked to the patient's EHR profile for audit readiness.
- Use a dedicated consent form that explicitly mentions APCM and 42 CFR Part 2.
- Failing to update consent annually or when the care plan changes significantly.
MAT Adherence & Naloxone Coordination Setup
Configure AI call workflows to automate monthly buprenorphine or methadone adherence checks, including queries about pharmacy access and current naloxone supply status.
- Schedule calls 5 days before the next MAT refill is due.
- Neglecting to document naloxone availability in the chronic care plan.
Automated Longitudinal Monitoring Logs
Utilize AI-driven phone interactions to log patient-reported outcomes (PROs) such as craving intensity and withdrawal symptoms directly into the EHR's chronic care module.
- Map AI data fields directly to EHR flowsheets for trend analysis.
- Storing monitoring data in unstructured 'sticky notes' that aren't billable.
Integration of Co-occurring Mental Health Data
Document interactions regarding depression or anxiety symptoms (PHQ-9/GAD-7) within the APCM note to satisfy BHI add-on requirements for complex SUD cases.
- Standardize the use of PHQ-9 and GAD-7 during the first call of each month.
- Treating co-occurring disorders as separate from the SUD care plan.
Relapse Prevention & Crisis Escalation Mapping
Define clear EHR documentation paths for patients reporting triggers or recent use during automated check-ins, ensuring immediate clinician notification and intervention logging.
- Set high-priority alerts for patients reporting a '7' or higher on craving scales.
- Delayed responses to reported triggers, which increases relapse risk.
Time-Tracking for Non-Face-to-Face Care
Automatically aggregate minutes spent on AI-managed outreach, care coordination, and pharmacy follow-ups to meet the minimum threshold for G0568-G0570 billing.
- Ensure your AI platform provides a granular log of interaction durations.
- Under-reporting time by ignoring the minutes spent on automated pharmacy coordination.
Monthly APCM Summary & Audit Trail Generation
Produce a comprehensive monthly summary within the EHR that synthesizes all automated and manual touchpoints, providing a clear audit trail for Medicare reimbursement.
- Review and sign off on the monthly APCM summary within 48 hours of month-end.
- Billing for APCM without a signed, comprehensive summary in the patient record.
Expected Outcomes
Increased APCM revenue through consistent capture of G0568-G0570 add-on codes.
Enhanced 42 CFR Part 2 compliance with automated, timestamped consent documentation.
Improved MAT retention rates via proactive, AI-managed adherence check-ins.
Reduced administrative burnout by automating routine longitudinal monitoring tasks.
Better clinical outcomes through real-time identification of relapse triggers.
Frequently Asked Questions
APCM focuses on the longitudinal management of chronic conditions like OUD, specifically allowing for BHI add-on codes (G0568-G0570) that reward the integration of behavioral health into primary addiction care.
Yes, provided the AI platform signs a Business Associate Agreement (BAA) and the workflow includes explicit, documented patient consent for the electronic handling of SUD-related information.
Documentation must show at least 20 minutes of clinical staff time per month spent on care coordination, MAT monitoring, or behavioral health integration tasks that are not part of the face-to-face encounter.
Yes, the time clinical staff spends reviewing AI-generated reports, managing escalated calls, and updating the EHR based on automated patient feedback counts toward the billable minutes.
Ready to transform your substance use disorders practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo